Delivery Order SPE2DB24D2101-SPE2DB25FKNFD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,809.76 to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packs (30-count) on August 15, 2025. This firm fixed-price delivery order, with performance completion targeted for August 18, 2025, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,935.50 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packs of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not include a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $5,093.43 for Alvimopan 12 mg capsules (unit dose, 30-count packages) with a completion date of September 5, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive...
- The Defense Logistics Agency awarded a $11,346.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose capsules of Alvimopan 12 mg, with a completion date of July 23, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The product is being delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packages (30-count) on August 14, 2025, with a ceiling value of $26,853.88 and an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,910.65 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count). The contract, which was competitively awarded with no set-aside designation, was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count), valued at $2,152.36 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $24,354.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medical product, and has an ultimate completion date of December 31, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB8A3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,615.12 firm fixed-price delivery order is for the supply of the medication Alvimopan 12 mg capsules, with a completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNFDDelivery Order
The Defense Logistics Agency awarded a $4,959.12 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Alvimopan 12 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion date of August 8, 2025, and performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The company competes for and receives delivery orders through open competition, demonstrating its capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/7/25 |